Ignite Creation Date:
2024-05-06 @ 1:50 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01916252
Status:
COMPLETED
Last Update Posted:
2017-09-27
First Post:
2013-07-30
Brief Title:
Bortezomib Velcade Lenalidomide Revlimid and IV Busulfan Busilvex in Patients Under 65 Years Old
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Organization Data
Organization:
PETHEMA Foundation
Class:
OTHER
Study ID:
GEM2012MENOS65
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PETHEMA Foundation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Janssen LP | INDUSTRY |
| Celgene | INDUSTRY |
| Pierre Fabre Medicament | INDUSTRY |